Search for: "IN RE WYETH"
Results 121 - 140
of 702
Sort by Relevance
|
Sort by Date
27 Feb 2014, 6:00 am
Wyeth, 719 F.3d 1245 (11th Cir. 2013), an appeal from this same court on prescription drug warnings claims under Florida law, and there [read post]
21 Feb 2014, 8:53 am
” In re Fosamax Products Liability Litigation, 2013 WL 174416, at *1 (S.D.N.Y. [read post]
31 Jan 2014, 2:00 pm
Wyeth Pharmaceuticals, Inc., 737 F.3d 378, 397 (6th Cir. 2013) (Tennessee would not apply consumer expectation test to drugs).In our prior “bullseye” post we praised In re Fosamax Products Liability Litigation, ___ F. [read post]
23 Jan 2014, 6:53 am
Wyeth, 4 A.3d 160 (Pa. [read post]
16 Jan 2014, 7:31 pm
For the patents as to which it did not timely file suit under § 154(b)(4), it was only Novartis’s failure to comply with reasonable filing deadlines that prevented it from securing any patent term adjustment authorized by Wyeth. [read post]
16 Jan 2014, 7:48 am
See In re Actos (Pioglitazone) Prods. [read post]
30 Dec 2013, 5:25 am
After the debacle in Wyeth v. [read post]
23 Dec 2013, 5:16 am
Super. 2013), and In re Reglan/Metoclopramide Litigation, 74 A.3d 221 (Pa. [read post]
19 Dec 2013, 6:12 am
Wyeth, Inc., 37 A.3d 549, 556 (N.J. [read post]
28 Nov 2013, 5:00 am
Wyeth Pharmaceuticals, Inc., 15 A.3d 909, 935 n.17 (Pa. [read post]
15 Nov 2013, 11:34 am
In re Schering Plo [read post]
14 Nov 2013, 7:41 am
Medtronic, Inc., 552 U.S. 312 (2008), Wyeth v. [read post]
31 Oct 2013, 5:00 am
The facts sound rather like Wyeth v. [read post]
21 Oct 2013, 1:57 pm
The plaintiff in In re Avandia Marketing, Sales Practices and Prods. [read post]
17 Oct 2013, 5:00 am
The learned intermediary rule could be Bob Dylan (I know, we’re showing our age, here). [read post]
14 Oct 2013, 10:22 am
Frankly, if you’re in an office in just about any town other than New York City, “you lose that battle, you lose that battle nine times out of ten. [read post]
19 Sep 2013, 9:53 am
., 712 F.3d 60 (1st Cir. 2013) – all of which also travel under the heading, In re Neurontin Marketing and Sales Practices Litigation. [read post]
12 Sep 2013, 7:37 am
So we’ve decided to take the plunge.We don’t have much quarrel with Dean Chemerinsky’s initial observation that the existing regime for preemption and prescription drug product liability litigation, fashioned by the trilogy of Wyeth v. [read post]
6 Sep 2013, 8:10 am
Wyeth, No. 12-6078, 2013 U.S. [read post]
5 Sep 2013, 12:24 pm
Because (as counsel noted) we are interested in preemption issues – even hard ones for our side, which certainly includes preemption in innovator drug cases post-Wyeth v. [read post]
